RxDoctor Payments DataLook up a doctor →

Christopher Gross, MD

Foot and Ankle Surgery · Charleston, SCNPI 1902034283

Payments from drug & device makers

$830,129in general payments, 2019–2025

Across 461 payments — averaging $1800.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$346K
  • Vilex LLC$163K
  • Stryker$117K
  • Alafair Biosciences, Inc.$59K
  • Acumed LLC$33K
  • Medshape, Inc.$29K
  • plus $82K from 39 others
$7,793in research payments, 2019–2025

Across 4 payments — averaging $1948.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Metric Medical Devices, Inc.$4K
  • Stryker$3K
  • Paragon 28, Inc.$598

What the payments were for

  • Royalty or licence$6,3772%
  • Consulting fees$307,75478%
  • Speaking & faculty fees$9,7212%
  • Grants$5470%
  • Travel & lodging$47,11612%
  • Food & beverage$21,0205%
  • Education$1,6070%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$830,129 in reported general payments places this provider in the 95th percentile of 87 foot and ankle surgery providers in South Carolina.

See all foot and ankle surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$475,959
Medicare patients
947
Services billed
13,314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib98$5,200
Vancomycin Hcl11$1,100
Cefazolin Sodium12$522
Gabapentin49$505
Pregabalin23$386
Meloxicam100$270
Diclofenac Sodium25$223
Cephalexin25$167
Methylprednisolone14$124
Doxycycline Hyclate12$83
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$62
Tramadol Hcl11$17

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →